131 related articles for article (PubMed ID: 6198297)
1. An in vitro study on the effects of isoprinosine on immune responses in cancer patients.
Tsang KY; Fudenberg HH; Pan JF; Gnagy MJ; Bristow CB
Int J Immunopharmacol; 1983; 5(6):481-90. PubMed ID: 6198297
[TBL] [Abstract][Full Text] [Related]
2. In vitro restoration of immune responses in aging humans by isoprinosine.
Tsang KY; Pan JF; Swanger DL; Fudenberg HH
Int J Immunopharmacol; 1985; 7(2):199-206. PubMed ID: 2409037
[TBL] [Abstract][Full Text] [Related]
3. Isoprinosine as an immunopotentiator in an animal model of human osteosarcoma.
Tsang KY; Fudenberg HH
Int J Immunopharmacol; 1981; 3(4):383-9. PubMed ID: 6174468
[TBL] [Abstract][Full Text] [Related]
4. Modulation of human T lymphocyte functions by isoprinosine.
Rey A; Cupissol D; Thierry C; Esteve C; Serrou B
Int J Immunopharmacol; 1983; 5(1):99-103. PubMed ID: 6188707
[TBL] [Abstract][Full Text] [Related]
5. Restoration of immune responses of aging hamsters by treatment with isoprinosine.
Tsang KY; Fudenberg HH; Gnagy MJ
J Clin Invest; 1983 Jun; 71(6):1750-5. PubMed ID: 6190840
[TBL] [Abstract][Full Text] [Related]
6. Effect of isoprinosine on natural killer cell activity of blood mononuclear cells in vitro and in vivo.
Hersey P; Edwards A
Int J Immunopharmacol; 1984; 6(4):315-20. PubMed ID: 6207121
[TBL] [Abstract][Full Text] [Related]
7. Effect of isoprinosine on lymphocyte proliferation and natural killer cell activity following thermal injury.
Singh H; Herndon DN
Immunopharmacol Immunotoxicol; 1989; 11(4):631-44. PubMed ID: 2483407
[TBL] [Abstract][Full Text] [Related]
8. In vivo effect of isoprinosine on interleukin-2 production, lymphocyte mitogenesis and NK activity in normal and cyclophosphamide immunosuppressed mice.
Barasoain I; Rejas MT; Ojeda G; Portolés MP; Rojo JM
Int J Immunopharmacol; 1986; 8(5):509-15. PubMed ID: 2428762
[TBL] [Abstract][Full Text] [Related]
9. Isoprinosine enhances PHA responses and has potential effect on natural killer cell (NK) activity of uremic patients in vitro.
Silvennoinen-Kassinen S; Karttunen R; Tiilikainen A; Huttunen K
Nephron; 1987; 46(3):243-6. PubMed ID: 2442634
[TBL] [Abstract][Full Text] [Related]
10. Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice.
Barasoain I; Rejas MT; Portoles MP; Ojeda G; Rojo JM
Int J Immunopharmacol; 1987; 9(4):489-96. PubMed ID: 2442109
[TBL] [Abstract][Full Text] [Related]
11. Modulatory effect of isoprinosine on lymphocyte proliferative response under immunodepressive conditions.
Portolés A; Ojeda G; Rojo JM; Portolés MP; Barasoain I
J Immunopharmacol; 1983; 5(3):245-56. PubMed ID: 6197489
[TBL] [Abstract][Full Text] [Related]
12. Isoprinosine and NPT 15392: immunomodulation and cancer.
Simon LN; Hoehler FK; McKenzie DT; Hadden JW
Adv Exp Med Biol; 1983; 166():241-59. PubMed ID: 6196956
[TBL] [Abstract][Full Text] [Related]
13. Preliminary characterization in mice of the effect of isoprinosine on the immune system.
Vecchi A; Sironi M; Spreafico F
Cancer Treat Rep; 1978 Nov; 62(11):1975-9. PubMed ID: 83191
[TBL] [Abstract][Full Text] [Related]
14. Isoprinosine effects on interleukin-1 production in acquired immune deficiency syndrome (AIDS).
Tsang KY; Donnelly RP; Galbraith GM; Fudenberg HH
Int J Immunopharmacol; 1986; 8(4):437-41. PubMed ID: 2427461
[TBL] [Abstract][Full Text] [Related]
15. [Action of isoprinosine on the "in vitro" activation of human lymphocytes (author's transl)].
Morin A; Griscelli C; Daguillard F
Ann Immunol (Paris); 1979; 130C(4):541-51. PubMed ID: 91345
[TBL] [Abstract][Full Text] [Related]
16. Isoprinosine stimulates granulocyte chemiluminescence and inhibits monocyte chemiluminescence in vitro.
Flø RW; Naess A; Albrektsen G; Solberg CO
APMIS; 1994 Apr; 102(4):249-54. PubMed ID: 7516672
[TBL] [Abstract][Full Text] [Related]
17. Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.
Tsang KY; Fudenberg HH; Galbraith GM; Donnelly RP; Bishop LR; Koopmann WR
J Clin Invest; 1985 May; 75(5):1538-44. PubMed ID: 2581997
[TBL] [Abstract][Full Text] [Related]
18. Suppressor cell activity after isoprinosine treatment of lymphocytes from normal mice.
Renoux G; Renoux M; Degenne D
Int J Immunopharmacol; 1979; 1(3):239-41. PubMed ID: 95251
[No Abstract] [Full Text] [Related]
19. Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases.
Nakamura T; Miyasaka N; Pope RM; Talal N; Russell IJ
Clin Exp Immunol; 1983 Apr; 52(1):67-74. PubMed ID: 6190598
[TBL] [Abstract][Full Text] [Related]
20. The effect of isoprinosine on the PHA response of monocyte-depleted and undepleted peripheral blood mononuclear cells.
Jacobsen PL; Greenspan JS
J Immunopharmacol; 1982-1983; 4(4):355-65. PubMed ID: 6192176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
